http://web.archive.org/web/20140817073449id_/http://www.dailymail.co.uk/news/article-2674377/FDA-approves-inhalable-insulin-diabetes-patients-billionaire-entrepreneur-lost-nearly-200-million-developing-it.html

by @entity0 and @entity1 the @entity2 on friday approved a long - delayed inhalable diabetes medication to help patients control their blood sugar levels during meals			1
the @entity2 cleared @entity8 's @entity7 , a fast - acting form of insulin , for adults with the most common form of diabetes , which affects more than 25 million @entity14			1
the approval decision comes more than three years after the agency first asked @entity8 to run additional clinical studies on the drug			0
inhaler : the device , which is about the size of a referee 's whistle , could replace injectable insulin tiny : other , similar devices have been much larger - some the size of a tennis ball - than the @entity7 device approval for the drug is a milestone for @entity8 , and its billionaire chief executive , 88 - year - old @entity31 , who has devoted much of his fortune to developing the revolutionary delivery system for the in - demand drug			1
' today ’s @entity2 action validates the years of clinical research and commitment that powered the development of this unique therapy , ' @entity31 said in a statement to the @entity41			2
demand for diabetes treatments is surging globally as the prevalence of obesity explodes			0
according to the @entity47 , roughly 347 million people worldwide have the disease , a chronic condition in which the body either does not make enough insulin to break down the sugar in foods or uses insulin inefficiently			1
it can lead to blindness , strokes , heart disease or death			0
in type 2 diabetes , the most common form of the disease , the body does not use insulin properly			1
type 1 diabetes is usually diagnosed in children and young adults			0
in those cases , the body does not produce insulin			0
@entity71 , an insulin powder , comes in a single - use cartridge and is designed to be inhaled at the start of a meal or within 20 minutes			1
@entity8 has said that patients using the drug can achieve peak insulin levels within 12 to 15 minutes			1
that compares to a wait time of an hour and a half or more after patients inject insulin			0
philanthropist : billionaire @entity31 lost nearly $ 200 million developing @entity7 the @entity2 said in its approval announcement that @entity71 is not a substitute for long - acting insulin and is a new option for controlling insulin levels during meals			1
the agency approved @entity71 with a boxed warning — the strongest type — indicating that the drug should not be used in patients with chronic lung diseases , such as asthma and smoker 's cough , due to reports of breathing spasms			2
the agency is also requiring several follow - up studies looking at the drug 's long - term safety , including its impact on the heart and lungs			2
@entity8 first submitted the drug to @entity2 in march 2009			0
the @entity110 , @entity111 - based company has no other products on the market and lost more than $ 191 million last year			2
@entity114 : @entity8 's lone product is @entity71 , which it has devoted hundreds of millions of dollars into developing several other companies have failed to make inhaled insulin work commercially			1
in 2007 , @entity119 discontinued its inhaled insulin @entity121 after it failed to gain ground on the market			0
in 2008 , @entity124 ended its development program , citing regulatory uncertainty			0
@entity8 shares fell 5.5 percent in regular trading after the @entity2 's approval announcement but rebounded 70 cents , or 7 percent , to $ 10.70 in after - hours trading friday .			0

@entity71 is a fast - acting form of insulin that can be inhaled rather than injected - to control blood - sugar levels
diabetes affects more than 25 million @entity14
billionaire philanthropist @entity31 has lost hundreds of millions of dollars developing the drug

@entity31:Alfred E. Mann
@entity2:FDA
@entity1:Ap
@entity0:Daily Mail Reporter
@entity7:Afrezza
@entity71:Afrezza
@entity8:MannKind
@entity47:World Health Organization
@entity14:Americans
@entity41:New York Times
@entity111:California
@entity110:Valencia
@entity124:Eli Lilly & Co.
@entity114:MnnKind Corp
@entity119:Pfizer Inc.
@entity121:Exubera